BeiGene
BGNE
#816
Rank
NZ$41.04 B
Marketcap
$355.90
Share price
-0.63%
Change (1 day)
23.83%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

We have found no dividend yield history for this company